A detailed history of Bank Of Montreal transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Bank Of Montreal holds 57,807 shares of IPA stock, worth $23,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,807
Previous 55,857 3.49%
Holding current value
$23,122
Previous $56,000 35.71%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.54 - $1.04 $1,053 - $2,028
1,950 Added 3.49%
57,807 $36,000
Q2 2024

Aug 14, 2024

BUY
$0.98 - $1.53 $2,010 - $3,139
2,052 Added 3.81%
55,857 $56,000
Q1 2024

May 13, 2024

BUY
$1.4 - $2.41 $8,797 - $15,144
6,284 Added 13.22%
53,805 $81,000
Q4 2023

Feb 08, 2024

SELL
$1.11 - $2.3 $147,475 - $305,580
-132,861 Reduced 73.66%
47,521 $81,000
Q3 2023

Nov 01, 2023

SELL
$1.76 - $3.04 $48,801 - $84,293
-27,728 Reduced 13.32%
180,382 $330,000
Q2 2023

Aug 02, 2023

SELL
$2.42 - $4.04 $79,545 - $132,794
-32,870 Reduced 13.64%
208,110 $616,000
Q1 2023

Jun 13, 2024

BUY
$2.77 - $5.49 $485,110 - $961,463
175,130 Added 325.49%
228,935 $634,000
Q4 2022

Feb 01, 2023

BUY
$4.5 - $5.72 $61,564 - $78,255
13,681 Added 6.02%
240,980 $1.26 Million
Q3 2022

Nov 10, 2022

BUY
$3.77 - $6.39 $124,918 - $211,732
33,135 Added 17.07%
227,299 $907,000
Q2 2022

Aug 11, 2022

BUY
$3.8 - $6.08 $204,098 - $326,556
53,710 Added 38.24%
194,164 $801,000
Q1 2022

May 12, 2022

BUY
$3.64 - $6.49 $197,087 - $351,401
54,145 Added 62.73%
140,454 $718,000
Q4 2021

Feb 11, 2022

BUY
$5.06 - $6.69 $202,450 - $267,666
40,010 Added 86.42%
86,309 $486,000
Q3 2021

Nov 12, 2021

BUY
$5.14 - $13.22 $5,525 - $14,211
1,075 Added 2.38%
46,299 $309,000
Q2 2021

Aug 12, 2021

BUY
$6.02 - $12.91 $272,248 - $583,841
45,224 New
45,224 $285,000

Others Institutions Holding IPA

About ImmunoPrecise Antibodies Ltd.


  • Ticker IPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,836,700
  • Market Cap $9.93M
  • Description
  • ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...
More about IPA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.